Kardigan, Inc. — Form SCHEDULE 13D/A
Filed October 1, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
Perceptive Advisors LLC filed an amended Schedule 13D/A on October 1, 2026, regarding beneficial ownership in Kardigan, Inc. (a pharmaceutical company with ~$721.8M in assets). The filing document itself contains no substantive disclosures of specific ownership percentages, share counts, dollar amounts, or details of what changed from the prior 13D filing—only metadata showing the amendment was filed.
Why this rating
Amendment to existing disclosure; no material transaction, deal, or ownership change specified in filing text. Routine regulatory update relative to company size.
See more from October 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.